Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy
F Leyva, A Zegard, F Umar, RJ Taylor, E Acquaye… - EP …, 2018 - academic.oup.com
Aims There is a continuing debate as to whether cardiac resynchronization therapy-
defibrillation (CRT-D) is superior to CRT-pacing (CRT-P), particularly in patients with non …
defibrillation (CRT-D) is superior to CRT-pacing (CRT-P), particularly in patients with non …
Cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy: a systematic review and meta-analysis
D Patel, A Kumar, E Black-Maier… - Circulation …, 2021 - Am Heart Assoc
Background: Cardiac resynchronization therapy (CRT) represents a major medical advance
in patients with heart failure with electrical dyssynchrony to improve symptoms, reduce …
in patients with heart failure with electrical dyssynchrony to improve symptoms, reduce …
Outcomes of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy
F Leyva, A Zegard, E Acquaye, C Gubran… - Journal of the American …, 2017 - jacc.org
Background: Recent studies have cast doubt on the benefit of cardiac resynchronization
therapy (CRT) with defibrillation (CRT-D) versus pacing (CRT-P) for patients with …
therapy (CRT) with defibrillation (CRT-D) versus pacing (CRT-P) for patients with …
Long‐term results of cardiac resynchronization therapy: a comparison between CRT‐pacemakers versus primary prophylactic CRT‐defibrillators
Background Cardiac resynchronization therapy (CRT) with or without a defibrillator has a
positive effect on mortality and morbidity for patients with heart failure. However …
positive effect on mortality and morbidity for patients with heart failure. However …
The addition of a defibrillator to resynchronization therapy decreases mortality in patients with nonischemic cardiomyopathy
Objectives The aim of this study was to determine whether patients with heart failure with
reduced ejection fraction (HFrEF) due to nonischemic etiology eligible for cardiac …
reduced ejection fraction (HFrEF) due to nonischemic etiology eligible for cardiac …
Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non …
CT Witt, MB Kronborg, EA Nohr, PT Mortensen… - Europace, 2016 - academic.oup.com
Aims Cardiac resynchronization therapy (CRT) improves symptoms, left ventricular function,
and survival in patients with heart failure (HF) and wide QRS. The benefit of adding …
and survival in patients with heart failure (HF) and wide QRS. The benefit of adding …
Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study
E Marijon, C Leclercq, K Narayanan… - European heart …, 2015 - academic.oup.com
Aims The choice of resynchronization therapy between with (CRT-D) and without (CRT-P) a
defibrillator remains a contentious issue. Cause-of-death analysis among CRT-P, compared …
defibrillator remains a contentious issue. Cause-of-death analysis among CRT-P, compared …
[HTML][HTML] Comparison between cardiac resynchronization therapy with and without defibrillator on long-term mortality: a propensity score matched analysis
Y Liang, J Wang, Z Yu, M Zhang, L Pan, Y Nie, Y Su… - Journal of …, 2020 - Elsevier
Background Cardiac resynchronization therapy (CRT)-defibrillator (CRT-D) has been more
widely implanted than CRT-pacemaker (CRT-P) in patients of heart failure with reduced …
widely implanted than CRT-pacemaker (CRT-P) in patients of heart failure with reduced …
The benefits of defibrillator in heart failure patients with cardiac resynchronization therapy: A meta‐analysis
YX Long, Y Hu, DY Cui, S Hu… - Pacing and Clinical …, 2021 - Wiley Online Library
Background Current guidelines did not provide recommendations on indications of an
additional implantable cardioverter‐defibrillator (ICD) to patients receiving cardiac …
additional implantable cardioverter‐defibrillator (ICD) to patients receiving cardiac …
Mortality and cardiac resynchronization therapy with or without defibrillation in primary prevention
Aims Cardiac resynchronization therapy with (CRTD) or without (CRTP) defibrillator is
recommended in selected patient with systolic chronic heart failure and wide QRS. There is …
recommended in selected patient with systolic chronic heart failure and wide QRS. There is …